Phase III trials of vadadustat in Japanese patients with anemia due to CKD meet primary endpoint March 12, 2019
New model of hemophagocytic lymphohistiocytosis points to possible therapeutic strategy March 6, 2019
BioCryst advancing factor D inhibitor BCX-9930 into clinic for complement-mediated diseases March 5, 2019
Apellis enters collaboration with SFJ Pharmaceuticals for APL-2 in hematologic indications March 1, 2019
RSS